Parkside Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.62M | Sell |
103,991
-16,566
| -14% | -$1.37M | 1.17% | 27 |
|
2025
Q1 | $9.78M | Sell |
120,557
-2,950
| -2% | -$239K | 1.44% | 22 |
|
2024
Q4 | $11.1M | Buy |
123,507
+2,050
| +2% | +$185K | 1.67% | 18 |
|
2024
Q3 | $12M | Buy |
121,457
+3,040
| +3% | +$300K | 1.81% | 15 |
|
2024
Q2 | $11M | Buy |
118,417
+24,665
| +26% | +$2.29M | 1.73% | 15 |
|
2024
Q1 | $8.9M | Buy |
93,752
+9,395
| +11% | +$891K | 1.41% | 29 |
|
2023
Q4 | $7.53M | Sell |
84,357
-2,000
| -2% | -$179K | 1.27% | 35 |
|
2023
Q3 | $6.31M | Sell |
86,357
-163
| -0.2% | -$11.9K | 1.16% | 39 |
|
2023
Q2 | $7.2M | Sell |
86,520
-3,075
| -3% | -$256K | 1.34% | 34 |
|
2023
Q1 | $6.83M | Buy |
89,595
+1,600
| +2% | +$122K | 1.29% | 36 |
|
2022
Q4 | $7.3M | Buy |
87,995
+1,200
| +1% | +$99.6K | 1.46% | 30 |
|
2022
Q3 | $6.88M | Buy |
86,795
+4,340
| +5% | +$344K | 1.48% | 32 |
|
2022
Q2 | $6.12M | Buy |
82,455
+545
| +0.7% | +$40.5K | 1.29% | 35 |
|
2022
Q1 | $7.36M | Buy |
81,910
+28,575
| +54% | +$2.57M | 1.44% | 25 |
|
2021
Q4 | $5.97M | Buy |
+53,335
| New | +$5.97M | 1.15% | 33 |
|
2021
Q1 | – | Sell |
-40,785
| Closed | -$5.74M | – | 93 |
|
2020
Q4 | $5.74M | Sell |
40,785
-6,725
| -14% | -$947K | 1.27% | 27 |
|
2020
Q3 | $5.29M | Sell |
47,510
-7,395
| -13% | -$824K | 1.39% | 22 |
|
2020
Q2 | $6.15M | Sell |
54,905
-12,290
| -18% | -$1.38M | 1.63% | 12 |
|
2020
Q1 | $5.2M | Sell |
67,195
-2,390
| -3% | -$185K | 1.72% | 12 |
|
2019
Q4 | $6.62M | Buy |
69,585
+5,700
| +9% | +$542K | 1.61% | 15 |
|
2019
Q3 | $4.87M | Buy |
63,885
+1,675
| +3% | +$128K | 1.3% | 24 |
|
2019
Q2 | $5.46M | Buy |
62,210
+47,195
| +314% | +$4.14M | 1.42% | 22 |
|
2019
Q1 | $1.36M | Buy |
15,015
+4,015
| +37% | +$363K | 0.37% | 70 |
|
2018
Q4 | $789K | Buy |
+11,000
| New | +$789K | 0.34% | 74 |
|